Engagement of Fas by FasL can also trigger proliferation of tumour cells (Lambert et al, 2003; Li et al, 2008) and increase tumour cell motility and invasiveness (Barnhart et al, 2004). The gene discussed is FASLG; the disease is neoplasm.